CLSA downgrades Charles River Labs stock rating on valuation
Covered in this story
What has happened since
- Charles River Laboratories is up 40.3% since this was published, 77 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
CLSA’s $219 target on $CRL is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.
CLSA’s track record →Analyst targets on Charles River Laboratories
- JPMorgan: $266 → $310 by Aug 2027 · Overweight via Investing.com
- Evercore ISI: $261 → $300 by Aug 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Charles River Laboratories →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.